Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: A European Osteosarcoma Intergroup Study

European Journal of Cancer

Volumn 41, Issue 2, 2005, Pages 225-230

  Nooij, M A ^a   Whelan, J ^b   Bramwell, V H C ^c   Taminiau, A T ^a   Cannon, S ^d   Hogendoorn, P C W ^a   Pringle, J ^d   Uscinska, B M ^e   Weeden, S ^e   Kirkpatrick, A ^f   Glabbeke, M V ^f   Craft, A W ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c TOM BAKER CANCER CENTRE   (Canada)

^d ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^e MRC CLINICAL TRIALS UNIT   (United Kingdom)

^f EORTC DATA CENTER   (Belgium)

^g ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Bone neoplasms; Chemotherapy; Leiomyosarcoma; Mesenchymal chondrosarcoma; Radiation sarcoma

Indexed keywords

CISPLATIN; DOXORUBICIN;

ADOLESCENT; ADULT; ALOPECIA; ARTICLE; BLEEDING; BONE CANCER; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; GRANULOCYTOPENIA; HEMATOLOGIC DISEASE; HUMAN; INFECTION; LEUKOPENIA; LIVER DISEASE; LUNG DISEASE; MALIGNANT FIBROUS HISTIOCYTOMA; METASTASIS; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROTOXICITY; OSTEOSARCOMA; OTOTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; SKIN DISEASE; SPINDLE CELL SARCOMA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RARE DISEASES; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 19944431704     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.08.026     Document Type: Article

References (10)

1. V.H.C. Bramwell, M. Burgers, and R. Sneath A comparison of two short intensive chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup J Clin Oncol 10 1992 1579 1591
2. Souhami RL, Craft AW, Eijken JW v/d, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997, 350, 911-917
3. V.H.C. Bramwell, W.P. Steward, and M. Nooij Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: a European Osteosarcoma Intergroup study J Clin Oncol 17 1999 3260 3269
4. G. Bacci, C. Cervellati, and P. Picci Adjuvant chemotherapy for localized malignant fibrous histiocytoma (MFH) of bone. Preliminary results Chem Oncol V 1981 59 65
5. M. Weiner, M. Sedlis, and A.D. Johnston Adjuvant chemotherapy of malignant fibrous histiocytoma of bone Cancer 51 1983 25 29
6. C. Urban, G. Rosen, and A.G. Huvos Chemotherapy of malignant histiocytoma of bone. A report of five cases Cancer 51 1983 795 802
7. S.P. Chawla, R.S. Benjamin, and F. Abdul-Karim Adjuvant chemotherapy of primary malignant fibrous histiocytoma of bone - prolongation of disease-free and overall survival Adjuv Ther Cancer IV 1984 621 629
8. A.G. Huvos, G. Rosen, and M. Dabska Mesenchymal chondrosarcoma. A clinicopathological analysis of 35 patients with emphasis on treatment Cancer 51 1983 1230 1237
9. A.T. Van Oosterom, and L.Y. Dirix Chondrosarcoma and other rare bone sarcomas Curr Opin Oncol 2 1990 495 499
10. A.D. Mitchell, K. Ayoub, D.C. Mangham, R.J. Frimer, S.R. Carter, and R.M. Tillman Experience in the treatment of dedifferentiated chondrosarcoma J Bone Joint Surg B 82 2000 55 61